Peanut Allergy Market: Advancements in Diagnosis and Treatment

Introduction:

The Global Peanut Allergy Market focuses on the development, commercialization, and use of diagnostic solutions and treatment options for individuals with peanut allergies. The market includes oral immunotherapy, allergen immunotherapy, emergency medications, and other therapeutic approaches designed to help manage allergic reactions and improve patient safety.

Increasing awareness of food allergies, rising demand for effective treatment options, advancements in allergen immunotherapy, and growing investment in allergy research are supporting market growth. Innovations in oral immunotherapy, epicutaneous immunotherapy, and personalized allergy management are further influencing the development of the global peanut allergy market.

Get Free Sample of This Premium Report: https://www.decisionsadvisors.com/request-sample/DAR4568

Global Peanut Allergy Market Insights

• The Global Peanut Allergy Market Size was valued at approximately USD 477.7 Million in 2024.
• The market is expected to grow at a CAGR of around 7.15% from 2025 to 2035.
• The worldwide market size is projected to reach approximately USD 1,021.4 Million by 2035.
• Asia-Pacific is expected to grow at the fastest rate during the forecast period, supported by increasing awareness of food allergies, improving healthcare infrastructure, and growing access to diagnostic and treatment services.

Other Key Findings

• Growing demand for effective peanut allergy management solutions is creating opportunities for pharmaceutical and biotechnology companies.
• Advances in oral immunotherapy and other allergen-specific treatments are expanding the range of potential management options.
• Increasing awareness among patients, caregivers, and healthcare professionals is supporting earlier diagnosis and improved allergy management.
• Ongoing clinical research and development activities are encouraging innovation in peanut allergy therapies.
• Rising demand for specialized allergy care and patient-focused treatment approaches is expected to contribute to market expansion.

Report Summary

Key Companies

Aimmune Therapeutics, DBV Technologies SA, Sanofi S.A., Pfizer Inc., ALK-Abelló A/S, Stallergenes Greer, Prota Therapeutics, Camallergy, Regeneron Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., and Others.
 

Want detailed insights, forecasts, and competitive analysis?

Explore the Global Peanut Allergy Market to understand emerging treatment opportunities, clinical developments, competitive strategies, and regional growth trends.
https://www.decisionsadvisors.com/reports/peanut-allergy-market